Is autologous transplant in relapsed DLBCL patients achieving only a PET+ PR appropriate in the CAR T-cell era? Shah NN, Ahn KW, Litovich C, He Y, et al. Blood 2021;137:1416-1423.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Shah NN, Ahn KW, Litovich C, He Y, et al. Is autologous transplant in relapsed DLBCL patients achieving only a PET+ PR appropriate in the CAR T-cell era? Blood 2021;137:1416-1423.
PMID: 33120429